Biologics Working Party documents

  • Email
  • Help

This page lists the documents published by the European Medicines Agency's Biologics Working Party.

Back to top

Document(s) Language Status First published Last updated Effective Date
Biologics Working Party report on viral safety of plasma-derived and urine-derived medicinal products with respect to Zika virus (English only)   2016-09-21    
Biologics Working Party (BWP) Ad-hoc Influenza Working Group: Amended European Union recommendations for the seasonal influenza vaccine composition for the season 2017/2018 (English only)   2017-03-24 2017-04-12  
Biologics Working Party Ad-hoc Influenza Working Group: European Union recommendations for the seasonal influenza vaccine composition for the season 2016/2017 (English only)   2016-04-04    
Biologics Working Party Ad-hoc Influenza Working Group: Amended European Union recommendations for the seasonal-influenza-vaccine composition for the season 2015 / 2016 (English only)   2015-03-27 2015-05-27  
Biologics Working Party Ad-hoc Influenza Working Group: European Union recommendations for the seasonal-influenza-vaccine composition for the season 2014 / 2015 (English only)   2014-03-21    
CHMP/Biologics Working Party report to the CMDh on pancreatin-containing products (English only)   2013-10-04    
Biologics Working Party Ad-hoc Influenza Working Group: Amended European Union recommendations for the seasonal-influenza-vaccine composition for the season 2013 / 2014 (English only) adopted 2012-03-16 2013-04-02  
Biologics Working Party Ad-hoc Influenza Working Group: European Union recommendations for the seasonal-influenza-vaccine composition for the season 2011 / 2012 (English only) adopted 2011-03-17    
European Union recommendations for the seasonal-influenza-vaccine composition for the season 2010 / 2011 (English only) adopted 2010-03-18    
Report of plasma master file epidemiology workshop with industry (English only)   2009-11-18    
Report: Expert workshop on Creutzfeldt-Jakob-disease risk and urine-derived medicinal products (English only)   2009-07-23    
European Union recommendation for the emergent-novel-H1N1-influenza-vaccine composition - Revised to include strain IVR-153 (English only) adopted 2009-06-10    
European Union recommendations for the seasonal-influenza-vaccine composition for the season 2009 / 2010 (English only) adopted 2009-04-23    
European Union recommendation for the seasonal-influenza-vaccine composition for the season 2008 / 2009 (English only) adopted 2008-03-18    
Biologics Working Party report to the CHMP: Beta-interferons and neutralising antibodies (in multiple sclerosis) (English only)   2008-02-12    
Report: Biologics Working Party, Process Analytical Technologies Group and industry (English only)   2007-07-16    
European Union recommendations for the influenza-vaccine composition for the season 2007 / 2008 (English only) adopted 2007-03-18    
European Union recommendations for the influenza-vaccine composition for the season 2006 / 2007 (English only) adopted 2006-05-29    
European Union recommendations for the influenza-vaccine composition for the season 2005 / 2006 (English only) adopted 2005-03-30    
First cases of bovine spongiform encephalopathy in the United States (USA) and Canada: Risk assessment of ruminant materials originating from the USA and Canada (English only) adopted 2004-07-21   2004-07-01
European Union recommendations for the influenza-vaccine composition for the season 2004 / 2005 (English only) adopted 2004-07-21    
CPMP position statement on West Nile virus and plasma-derived medicinal products (English only) adopted 2003-07-25   2003-07-25
Final European Union recommendation for influenza-vaccine composition for the season 2003 / 2004 (English only) adopted 2002-03-18    
CPMP position statement - non-remunerated and remunerated donors: safety and suply of plasma-derived medicinal products (English only) adopted 2002-05-30    
European Medicines Agency workshop on the plasma master file, 10-11 October 2001: Summary report (English only)   2002-12-17    
Final European Union recommendations for the influenza-vaccine composition for the season 2002 / 2003 (English only) adopted 2002-03-20    
European Medicines Agency workshop on viral safety of plasma-derived medicinal products with particular focus on non-enveloped viruses, 13 September 2000: Summary report (English only) adopted 2001-03-28    
European Medicines Agency expert meeting on human transmissible spongiform encephalopathies and medicinal products derived from human blood and plasma, 1 December 2000: Summary report (English only)   2001-03-28    
Questions and answers on bovine spongiform encephalopathies and vaccines (English only) adopted 2001-04-24   2001-04-24